Kilitch Drugs (India) Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
KILITCH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kilitch Drugs (India) Limited has informed the stock exchanges that its trading window will remain closed for designated persons and their immediate relatives from October 1, 2025, until 48 hours after the declaration of unaudited financial results for the quarter ended September 30, 2025. This closure is in line with SEBI's Prohibition of Insider Trading Regulations, 2015 and the company's internal insider trading code. The company has also stated that the date of the board meeting to approve the Q2 FY26 results will be communicated later. The intimation has been signed by Mukund Mehta, Managing Director.
This is a routine compliance announcement and does not directly impact shareholders or the stock price. It signals that the company is preparing to announce its September quarter results in the coming weeks, which investors should watch for.